A detailed history of Hudson Bay Capital Management LP transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 208,064 shares of SLN stock, worth $3.76 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
208,064
Previous 276,590 24.78%
Holding current value
$3.76 Million
Previous $5.97 Million 33.83%
% of portfolio
0.02%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$18.31 - $23.91 $1.25 Million - $1.64 Million
-68,526 Reduced 24.78%
208,064 $3.95 Million
Q1 2024

May 15, 2024

BUY
$17.39 - $26.25 $4.81 Million - $7.26 Million
276,590 New
276,590 $5.97 Million

Others Institutions Holding SLN

About Silence Therapeutics plc


  • Ticker SLN
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,888,400
  • Market Cap $649M
  • Description
  • Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...
More about SLN
Track This Portfolio

Track Hudson Bay Capital Management LP Portfolio

Follow Hudson Bay Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.